Inovio Pharmaceuticals Inc
INO
Market Cap$83.25M
Close$
$-1.24
159.5% downside
Current Fair Value
159.5% downsideOvervalued by 159.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $83.25 Million |
|---|---|
| Enterprise Value | $-28,561,239,112.00 |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-3.95 |
| Beta | 1.31 |
| Outstanding Shares | 38,613,653 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | 1.04 |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | -283.12 |
| Enterprise Value to EBIT | 0.33 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.39 |
| Debt to Equity | 0.22 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Inovio Pharmaceuticals Inc
CEO: Jong Kim